WO2026033010 - PHYTOLOGICAL COMPOSITION AS A HEMOSTATIC AGENT
National phase entry is expected:
Publication Number
WO/2026/033010
Publication Date
12.02.2026
International Application No.
PCT/EP2025/072575
International Filing Date
06.08.2025
Title **
[English]
PHYTOLOGICAL COMPOSITION AS A HEMOSTATIC AGENT
[French]
COMPOSITION PHYTOLOGIQUE UTILISÉE EN TANT QU'AGENT HÉMOSTATIQUE
Applicants **
BOGONI, Sebastiano Stefano Giuseppe
PHYTOHEAL MEDTECH INTERNATIONAL
Inventors
POLIMENO, Tiziana Rosa Natalina
Priority Data
102024000018601
07.08.2024
IT
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2110 | |
| EPO | Filing, Examination, Granting | 9698 | |
| Japan | Filing, Examination, Granting | 2263 | |
| South Korea | Filing, Examination, Granting | 2236 | |
| USA | Filing, Examination, Granting | 12540 |
Total:
28,847
Contact Us
Abstract[English]
The present invention relates to a phytological composition as a hemostatic agent, for example for use in the treatment of wounds and/or bleeding lesions of the skin and/or mucous membranes. The phytological composition consists of a polysaccharide of Tremella fuciformis, an extract of leaves of Vitis vinifera, an extract of leaves of Astragalus membranaceus, an extract of Medicago sativa, an extract of Fucus vesiculosus, a powder of Spirulia platensis, an extract of root of Beta vulgaris and an extract of Polygonum cuspidatum. The present invention also relates to pharmaceutical formulations comprising said phytological composition together with suitable pharmaceutically acceptable excipients.[French]
La présente invention concerne une composition phytologique utilisée en tant qu'agent hémostatique, par exemple destinée à être utilisée dans le traitement de plaies et/ou de lésions hémorragiques de la peau et/ou des muqueuses. La composition phytologique est constituée d'un polysaccharide de Tremella fuciformis, d'un extrait de feuilles de Vitis vinifera, d'un extrait de feuilles d'Astragalus membranaceus, d'un extrait de Medicago sativa, d'un extrait de Fucus vesiculosus, d'une poudre de Spirulia platensis, d'un extrait de racine de Beta vulgaris et d'un extrait de Polygonum cuspidatum. La présente invention concerne également des formulations pharmaceutiques comprenant ladite composition phytologique conjointement avec des excipients pharmaceutiquement acceptables appropriés.